Targeted therapies for previously treated advanced or metastatic renal cell carcinoma: systematic review and network meta-analysis

OBJECTIVE: To compare the effectiveness and safety of treatments for advanced or metastatic renal cell carcinoma (amRCC) after treatment with vascular endothelial growth factor (VEGF)-targeted treatment. DESIGN: Systematic review and network meta-analysis of randomised controlled trials (RCTs) and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Karner, Charlotta, Kew, Kayleigh, Wakefield, Victoria, Masento, Natalie, Edwards, Steven J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429896/
https://www.ncbi.nlm.nih.gov/pubmed/30826762
http://dx.doi.org/10.1136/bmjopen-2018-024691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429896/
https://www.ncbi.nlm.nih.gov/pubmed/30826762
http://dx.doi.org/10.1136/bmjopen-2018-024691

Ejemplares similares